AstraZeneca Pharma India Limited engages in the manufacture, distribution, and marketing of pharmaceutical products in India and internationally. It operates in three segments: Healthcare, Clinical Trial Services, and Co-promotional Services. The company primarily provides products in the areas of cardiovascular, gastrointestinal, infection, neuroscience, oncology, and respiratory and inflammation healthcare. Its products include Betaloc, Seloken XL, Imdur, Crestor, Seloram, Vigocil, Vigocil M, Nitract SR, Valfect,Olways, Olways H, Olways AM for cardiovascular diseases; and Onglyza, Kombiglyze XR, and Byetta for diabetes. The company also offers Mit’s Linctus Codeinae Co, Mit’s Linctus DX, Bricarex, Bricarex A, Bricacef, Bricacef PED, Bricanyl Syrup, and Symbicort for respiratory diseases; Prostodin, Cerviprime, and Partocin for maternal healthcare; Arimidex, Nolvadex, Iressa, Zoladex, Casodex, and Faslodex for oncology; and Meronem, Vancocin CP, Enclere, and Remergin for infections. In addition, it provides Xylocaine, Sensorcaine, Diprivan, and Naropin for neuroscience; and Neksium tablets and injections for gastrointestinal diseases. The company was incorporated in 1979 and is headquartered in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
astrazeneca pharma india ltd
Post box No. 2483
Off Bellary Road
Phone: 91 80 6774 8000
Fax: 91 80 2362 2015www.astrazenecaindia.com
|No competitor information is available for ASTR.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact ASTRAZENECA PHARMA INDIA LTD, please visit www.astrazenecaindia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.